Takeo Toshima

Dr. Takeo Toshima

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2022 in Cancer Science
Verified
Journal Article
Open access
NINorifumi Iseda
Norifumi Iseda
SIShinji Itoh
Shinji Itoh
KTKatsuya Toshida
Katsuya Toshida
TTTakahiro Tomiyama
Takahiro Tomiyama
AMAkinari Morinaga
Akinari Morinaga
MMMasaki Mori
Masaki Mori
The tyrosine kinase inhibitor lenvatinib is used to treat advanced hepatocellular carcinoma (HCC). Ferroptosis is a type of cell death characterized by the iron‐dependent accumulation of lethal lipid reactive oxygen species (ROS). Nuclear factor erythroid‐derived 2‐like 2 (Nrf2) protects HCC cells against ferroptosis. However, the mechanism of lenvatinib‐induced cytotoxicity and the relationships between lenvatinib resistance and Nrf2 are unclear. Thus, we investigated the relationship between lenvatinib and ferroptosis and clarified the involvement of Nrf2 in lenvatinib‐induced cytotoxicity. Cell viability, lipid ROS levels, and protein expression were measured using Hep3B and HuH7 cells treated with lenvatinib or erastin. We examined these variables after silencing fibroblast growth factor receptor‐4 (FGFR4) or Nrf2 and overexpressing‐Nrf2. We immunohistochemically evaluated FGFR4 expression in recurrent lesions after resection and clarified the relationship between FGFR4 expression and lenvatinib efficacy. Lenvatinib suppressed system Xc− (xCT) and glutathione peroxidase 4 (GPX4) expression. Inhibition of the cystine import activity of xCT and GPX4 resulted in the accumulation of lipid ROS. Silencing‐FGFR4 suppressed xCT and GPX4 expression and increased lipid ROS levels. Nrf2‐silenced HCC cells displayed sensitivity to lenvatinib and high lipid ROS levels. In contrast, Nrf2‐overexpressing HCC cells displayed resistance to lenvatinib and low lipid ROS levels. The efficacy of lenvatinib was significantly lower in recurrent HCC lesions with low‐FGFR4 expression than in those with high‐FGFR4 expression. Patients with FGFR4‐positive HCC displayed significantly longer progression‐free survival than those with FGFR4‐negative HCC. Lenvatinib induced ferroptosis by inhibiting FGFR4. Nrf2 is involved in the sensitivity of HCC to lenvatinib.

26 January 2011 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
TTTakeo Toshima
Takeo Toshima
KSKen Shirabe
Ken Shirabe
KTKazuki Takeishi
Kazuki Takeishi
TMTakashi Motomura
Takashi Motomura
YMYouhei Mano
Youhei Mano
YMYoshihiko Maehara
Yoshihiko Maehara

17 October 2019 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
TTTakeo Toshima
Takeo Toshima
TYTomoharu Yoshizumi
Tomoharu Yoshizumi
YKYukiko Kosai‐Fujimoto
Yukiko Kosai‐Fujimoto
SIShoichi Inokuchi
Shoichi Inokuchi
SYShohei Yoshiya
Shohei Yoshiya
MMMasaki Mori
Masaki Mori

26 March 2021 in Hepatology Communications
Verified
Journal Article
Open access
PDF file
SIShinji Itoh
Shinji Itoh
TYTomoharu Yoshizumi
Tomoharu Yoshizumi
YKYoshiyuki Kitamura
Yoshiyuki Kitamura
KYKyohei Yugawa
Kyohei Yugawa
NINorifumi Iseda
Norifumi Iseda
MMMasaki Mori
Masaki Mori
We evaluated the prognostic value of fluorine‐18 fluorodeoxyglucose (18F‐FDG) positron emission tomography/computed tomography (PET/CT) in hepatocellular carcinoma (HCC). Their association with programmed death ligand 1 (PD‐L1) expression and vascular formation was further investigated. In this retrospective study, using a database of 418 patients who had undergone 18F‐FDG PET/CT before hepatic resection for HCC, immunohistochemical staining of PD‐L1, clusters of differentiation (CD) 8, CD68, and CD34 was performed. Patients with a high maximum standardized uptake value (SUVmax) on 18F‐FDG PET/CT showed a significantly worse recurrence‐free survival (RFS) (hazard ratio [HR]: 1.500; 95% confidence interval [CI]: 1.088‐2.069; P = 0.0133) and overall survival (OS) (HR: 2.259; 95% CI: 1.276‐4.000; P = 0.0052) than patients with a low SUVmax. Logistic regression analysis showed that a high SUVmax in HCC was significantly associated with PD‐L1‐positive expression (odds ratio: 4.407; 95% CI: 2.265‐8.575; P < 0.0001). SUVmax values of HCC were associated with intratumoral CD8‐positive T‐cell counts (P = 0.0044) and CD68‐positive macrophage counts (P = 0.0061). Stratification based on SUVmax, PD‐L1 expression, and the vessels that encapsulate tumor clusters (VETC) status was also significantly associated with RFS and OS. SUVmax, VETC, and PDL1 expression were independently predictive of survival on multivariable analysis. Conclusion: Our large cohort study showed that a high SUVmax on 18F‐FDG PET/CT is associated with a poor clinical outcome and PD‐L1 expression in patients with HCC. Additionally, stratification of patients based on the combination of SUVmax, PD‐L1 expression, and the VETC status predicts poor clinical outcome.

5 June 2021 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
JKJunji Kawasaki
Junji Kawasaki
TTTakeo Toshima
Takeo Toshima
Tomoharu YoshizumiTomoharu Yoshizumi
Tomoharu Yoshizumi
SIShinji Itoh
Shinji Itoh
YMYohei Mano
Yohei Mano
MMMasaki Mori
Masaki Mori

9 March 2022 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
SIShinji Itoh
Shinji Itoh
TTTakahiro Tomiyama
Takahiro Tomiyama
AMAkinari Morinaga
Akinari Morinaga
TKTakeshi Kurihara
Takeshi Kurihara
YNYoshihiro Nagao
Yoshihiro Nagao
Tomoharu YoshizumiTomoharu Yoshizumi
Tomoharu Yoshizumi
Aim: This study aimed to clarify the clinical effects of the indocyanine green (ICG)‐fluorescence imaging (FI) technique for determination of liver transection lines during laparoscopic partial liver resection for liver tumors.Methods: This was a retrospective study including 112 patients who underwent laparoscopic partial liver resection for liver tumors. These enrolled patients were divided into an ICG‐FI group (n = 55) and a non‐ICG‐FI group (n = 57) according to the availability of the ICG‐FI. The clinicopathological characteristics of patients between two groups were compared before and after propensity score matching.Results: The ICG‐FI and non‐ICG‐FI groups differed at baseline in terms of ICG retention rate at 15 min. After propensity score matching, two comparable groups of 32 patients each were obtained. The negativity rated of the pathological surgical margins were comparable between the two groups before and after propensity score matching. However, the surgical margins were significantly wider in the ICG‐FI group before and after propensity score matching (P = .039 and P = .047, respectively).Conclusion: The ICG‐fluorescence imaging technique may offer clinical benefits in terms of a secure surgical margin in laparoscopic partial liver resection.